Aging and HIV-related cognitive loss

JAMA

Volumn 308, Issue 4, 2012, Pages 349-350

  Mateen, Farrah J ^a   Mills, Edward J ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

AGING; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG PENETRATION; EPIDEMIC; HEALTH CARE COST; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; LIFE EXPECTANCY; MENTAL DETERIORATION; NONHUMAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; REHABILITATION CARE; SHORT SURVEY; SOCIAL SUPPORT; VIREMIA;

EID: 84864125256     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.8538     Document Type: Short Survey

References (10)

1. Valcour V, Paul R, Chiao S, Wendelken LA, Miller B. Screening for cognitive impairment in human immunodeficiency virus. Clin Infect Dis. 2011;53(8):836-842.
2. Cysique LA, Bain MP, Brew BJ, Murray JM. The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future. Sex Health. 2011;8(4):541-550.
3. Wong MH, Robertson K, Nakasujja N, et al. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology. 2007;68(5):350-355. (Pubitemid 46184210)
4. Smurzynski M, Wu K, Letendre S, et al. Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS. 2011;25(3):357-365.
5. Negin J, Cumming RG. HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. Bull World Health Organ. 2010;88(11):847-853.
6. Centers for Disease Control and Prevention. Diagnoses of HIV infection and AIDS in the US and dependent areas, 2009. HIV Surveillance Report, vol 21. http://www.cdc.gov/hiv/surveillance/resources/reports/2009report/. Accessed February 28, 2012.
7. Heaton RK, Franklin DR, Ellis RJ, et al CHARTER Group; HNRC Group. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3-16.
8. Simioni S, Cavassini M, Annoni JM, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24(9):1243-1250.
9. Robertson KR, Smurzynski M, Parsons TD, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007;21(14):1915-21. (Pubitemid 47329768)
10. Walensky RP, Wolf LL, Wood R, et al. When to start antiretroviral therapy in resource-limited settings. Ann Intern Med. 2009;151(3):157-66.